Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000711377-25-000075
Filing Date
2025-11-07
Accepted
2025-11-07 12:12:52
Documents
2
Period of Report
2025-08-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 3344
2 EXHIBIT 24_POWER OF ATTORNEY exhibit_24.txt EX-24 4261
  Complete submission text file 0000711377-25-000075.txt   8979
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address
Nassif Mikheal (Reporting) CIK: 0002082158 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-17988 | Film No.: 251461451